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Background: Irritable bowel syndrome (IBS) is characterized by chronic visceral hyperalgesia (CVH) that manifested
with persistent or recurrent abdominal pain and altered bowel movement. However, the pathogenesis of the CVH
remains unknown. The aim of this study was to investigate roles of endogenous hydrogen sulfide (H2S) producing
enzyme cystathionine beta-synthetase (CBS) and p65 nuclear factor-kappa B subunits in CVH.
Results: CVH was induced by neonatal maternal deprivation (NMD) in male rats on postnatal days 2–15 and
behavioral experiments were conducted at the age of 7–15 weeks. NMD significantly increased expression of CBS in
colon-innervating DRGs from the 7th to 12th week. This change in CBS express is well correlated with the time
course of enhanced visceromoter responses to colorectal distention (CRD), an indicator of visceral pain.
Administration of AOAA, an inhibitor of CBS, produced a dose-dependent antinociceptive effect on NMD rats while
it had no effect on age-matched healthy control rats. AOAA also reversed the enhanced neuronal excitability seen
in colon-innervating DRGs. Application of NaHS, a donor of H2S, increased excitability of colon-innervating DRG
neurons acutely dissociated from healthy control rats. Intrathecal injection of NaHS produced an acute visceral
hyperalgesia. In addition, the content of p65 in nucleus was remarkably higher in NMD rats than that in
age-matched controls. Intrathecal administration of PDTC, an inhibitor of p65, markedly reduced expression of CBS
and attenuated nociceptive responses to CRD.
Conclusion: The present results suggested that upregulation of CBS expression, which is mediated by activation of
p65, contributes to NMD-induced CVH. This pathway might be a potential target for relieving CVH in patients with
IBS.
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Irritable bowel syndrome (IBS) is a common gastrointes-
tinal disorder characterized by abdominal pain in associ-
ation with altered bowel movements without a
demonstrable pathology. The visceral hypersensitivity is
an important neurophysiological mechanism in patients
with IBS [1]. Recent studies in rodents found that early
life stress by neonatal maternal deprivation (NMD)
could induce intestinal mucosal dysfunction and visceral
hypersensitivity at the adult stage in rats, mimicking
main pathophysiological characteristics of IBS in human
[2,3]. Indeed, early traumatic experiences such as child-
hood neglect, abuse, loss of a parent, and life-
threatening situations during childhood have been
shown to increase the risk of IBS development in human
[4]. The NMD-induced visceral hypersensitivity is dis-
tinct from those of inflammatory pain and neuropathic
pain in that it produces visceral hyperalgesia without in-
flammatory responses in the gut mucosa, a characteristic
of IBS. Unfortunately, visceral pain of IBS cannot be ef-
fectively treated at the present time partially because its
pathophysiology is not well understood.
Progress has been made during last several decades in
understanding the development of visceral hypersensitiv-
ity. Hydrogen sulfide was discovered to be one of princi-
pal molecules to modulate nociceptive processes in
primary afferents including those that innervate visceral
organs. It has been recently shown that cystathionine β-
synthetase (CBS) signaling pathway plays an important
role in the induction of both acute and chronic pain.
H2S participated in formalin-induced peripheral inflam-
matory pain in hindpaws of rats [5]. It also enhanced
carrageennan-induced hindpaw oedema in the rats, and
this effect may be mediated by increasing the activity of
myeloperoxidase. Both intrathecal and intraplantar injec-
tion of NaHS activated T-type Cav3.2 and then lead to
peripheral mechanical hyperalgesia [6,7]. H2S contri-
butes to the generation of visceral hyperalgesia not only
in the peripheral somatosensory system but also in the
visceral organs [8]. Since CBS is the predominant source
of H2S synthesis in the colon of rodents [9], we investi-
gated function and regulation of CBS-H2S signaling
pathway in the NMD-induced visceral hyperalgesia.
Emerging evidence has also indicated that the activa-
tion of nuclear factor kappa B (NF-κB) following periph-
eral inflammation or nerve injuries is related to the
generation of hyperalgesia or allodynia [10,11], but its
roles in CHV has not been fully studied. Chronic nerve
injury could result in an increase in the expression of
phospho-NF-κB (p-NF-κB) in astrocytes and p-NF-κB
was shown to participate in tactile allodynia [12-14].
During peripheral and spinal nerve injuries, activity of
NF-κB was increased in injury-related DRGs and spinal
segments [15-17]. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic
nerve at physiological doses evoked signs of neuropathic
pain [18]. Intrathecal pretreatment with NF-κB inhibi-
tors attenuated the allodynia produced by sciatic neur-
opathy [11,15,19-22]. These lines of evidence indicate
that NF-κB, a classic transcription factor, is a key regula-
tor of genes involved in the response to inflammation
and stress [23-25]. Previous studies have mainly focused
on the regulation of NF-κB in gene expression of pro-
inflammatory cytokines such as TNF-α, IL-1β, IL-6 and
prostaglandins [11,26,27]. Attention has not been well
paid to the action of NF-κB on CBS-H2S signaling, a
pathway that is particularly important for the generation
of visceral hypersensitivity and chronic visceral pain.
As an extension of our previous work in peripheral
sensitization of NMD-induced visceral hyperalgesia, in
this study, we focused on changes in expression and
function of endogenous H2S-producing enzyme CBS
and NF-κB in colon-innervating DRGs in adult rats with
NMD. Our findings indicate that upregulation of CBS
expression mediated by translocation of p65 from cyto-
plasm to nucleus contributes to NMD-induced CVH.
This provides a mechanistic insight into CVH from a
neurobiological perspective.
Methods
Induction of chronic visceral hypersensitivity
Experiments were performed on male Sprague–Dawley
rats. Care and handling of all animals were approved by
the Institutional Animal Care and Use Committee of
Soochow University and were in accordance with the
guidelines of the International Association for the Study of
Pain. Chronic visceral hypersensitivity (CVH) was induced
by neonatal maternal deprivation (NMD), a rat model
described previously [2,28]. Briefly, pups were separated
from their dams for 3 hours once a day on postnatal day
2–15 with the temperature maintained at ~32°C. After
the separation period, pups were returned to their mater-
nity cages housed as a group. Pups in no handing group
were raised with their dams as age- and sex-matched
controls (CON). On PND 21~22, pups were weaned and
housed in individual cages in the same way for both
CON and NMD groups. All experiments were performed
at the age of 7–15 weeks. In the present study, a total of
200 male rats were used, of which 83 rats was in CON
group (n = 40 for behavioral studies, n = 14 for excitabil-
ity recordings, n = 29 for Western blotting), and 117 rats
(n = 72 for behavioral studies, n = 11 for excitability
recordings, n = 34 for Western blotting) in NMD group.
Behavioral studies to measure nocifensive responses to
graded CRD
Visceral hypersensitivity was measured at postnatal
7–15 weeks by observing the response of rats to
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[29,30]. In brief, a flexible balloon (6 cm) constructed
from a surgical glove finger attached to a tygon tubing
was inserted 8 cm into the descending colon and rectum
via the anus and held in place by taping the tubing to
the tail. Rats were placed in small Lucite cubicles and
allowed to adapt for 30 minutes. CRD was performed by
rapidly inflating the balloon to a constant pressure mea-
sured using a sphygmomanometer connected to a pres-
sure transducer. The balloon was inflated to various
pressures: 20, 40, 60 and 80 mmHg, for a 20 second
stimulation period followed by a 2 minute rest. Behav-
ioral responses to CRD were measured by visual observa-
tion of the abdominal withdrawal reflex (AWR) by a
blinded observer and the assignments of an AWR score
were as follows: 0=no response to given pressure;
1=slight head movement without abdominal muscle con-
traction; 2=Contraction of abdominal muscles; 3=lifting
of abdominal wall; 4=Body arching and lifting of pelvic
structures. The experimenter, who assigned the AWR
scores and performed the EMG analysis, was masked to
the control or NMD group assignment and the drug
treatment group as well.
To minimize the possible insult from the repetitive
distention stimuli of the colon, distention threshold
was measured in this study. Distension threshold (DT)
was the minimal distention pressure to evoke abdom-
inal visceromotor response. It was recorded in mmHg
by giving a steady increase in distention pressure by
sphygmomanometer.
Cell fractionation
Owing to small content of nuclear protein in one DRG,
proteins of 24 DRGs from 4 rats from each group were
pooled together as one sample. Thus total twelve rats
from CON and NMD group were used in this experi-
ment. Nuclear protein was extracted by NE-PER nuclear
and cytoplasmic extraction reagents (Thermo) according
to manufactures instruction. Briefly, immediately before
use, 1% (v/v) protease inhibitors (Roche) were added to
the reagents. Twenty milligram DRGs were homoge-
nized using glass grinder with the indicated 200 μl cyto-
plasmic extraction reagent and vortexed vigorously for
15s and then incubated on the ice for 10min. Next 11μl
of the second regent was added to the suspension for
1 min. The suspension was centrifuged at 16000 rpm for
5 min at 4°C. The supernatant (cytoplasmic fraction)
were collected and stored at −80°C. Sedimented nuclei
were gently resuspended in 100 μl of ice-cold nuclear
extraction regent and 1% (v/v) protease inhibitors,
incubated on ice, vortexed for 15s every 10 min, for
a total of 40 min. The suspension was centrifuged at
16000 rpm for 10 min at 4°C. The supernatant (nuclear
fraction) was transferred to a pre-chilled tube and storedat −80°C until use. Protein concentration was determined
by the Bradford method (Beyotime).
Western blot
DRGs (T13-L2) from control rats or NMD rats were dis-
sected out and lyzed in 100 μl of radioimmunoprecipita-
tion assay buffer containing 1% NP-40, 0.5%Na
deoxycholate, 0.1% SDS, PMSF (10 μl/ml), and aprotinin
(30 μl/ml; Sigma). The cell lysates were then microfuged
at 15,000 rpm for 30 min at 4°C. The concentration of
protein in homogenate was determined using a BCA re-
agent (Beyotime, CHN). Twenty micrograms of proteins
were loaded onto a 10% Tris–HCl SDS-PAGE gel (Bio-
Rad, Hercules, CA). After electrophoresis, the proteins
were electrotransferred onto polyvinylidenedifluoride
membranes (Millipore) at 200 mA for 2 hr at 4°C. The
membranes were incubated in 25 ml of blocking buffer
(1XTBS with 5% w/v fat-free dry milk) for 2 hr at room
temperature. The membrane was then incubated with
the primary antibodies at 4°C overnight. Primary anti-
bodies used were mouse anti-CBS (1:1000; Abnova,
Taiwan, CHN) and mouse anti-NF-κB (1:200; Santa
Cruz, California, USA). After incubation, membranes
were washed with TBST (1XTBS and 0.5% Tween-20)
three times for 15 min each and incubated with anti-
mouse HRP-conjugated secondary antibody (1:4000;
Chemicon) for 2 hr at room temperature. The membrane
was then washed with TBST three times for 15 min each.
The immunoreactive proteins were detected by enhanced
chemiluminescence (ECL kit; Amersham Biosciences,
Arlington Heights, IL). Bands recognized by primary
antibody were visualized by exposure of the membrane
onto an x-ray film. Then membrane was striped and re-
probed for β-actin (anti-actin 1:1000, Multisciences,
CHN) or H3 (anti-H3, 1:1000, Sigma, USA). For quantifi-
cation of the objective protein levels, the photographs
were digitized and analyzed using a scanner (Bio-Rad im-
aging system Bio-Rad GelDoc XRS+). All samples were
normalized to β-actin or H3 as control.
Cell labeling
Colon specific DRG neurons were labeled by injection of
1, 1'-dioleyl-3, 3, 3', 3-tetramethylindocarbocyanine
methanesulfonate (DiI, Invitrogen) into the colon wall
[30]. Briefly, when the rats were 6 weeks old, animals
were anaesthetized with ketamine (80 mg/kg, i. p.) plus
xylazine (5~10 mg/kg, i. p.). The abdomen was opened
by midline laparotomy and the colon was exposed. DiI,
25 mg in 0.5 ml methanol, was injected in ~1 μl volume
at 10 sites on the exposed colon extending from the
level of the bladder to about 6 cm in an oral direction.
To prevent leakage and possible contamination of adja-
cent organs with the dye, the needle was left in place for
1 min and each injection site was washed with normal
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swabbed prior to closing of the abdomen. Animals were
returned to their cages and given free access to drinking
water and standard food pellets.
Whole-cell patch clamp recordings
Ten days after DiI injection, NMD or control rats were
killed by cervical dislocation, followed by decapitation
[31]. Bilateral DRGs (T13-L2) were dissected out and
transferred to an ice-cold, oxygenated fresh dissecting
solution, containing (in mM): 130 NaCl, 5 KCl, 2 KH2PO4,
1.5 CaCl2, 6 MgSO4, 10 glucose and 10 HEPES, pH 7.2
(osmolarity: 305 mOsm). After removal of the connective
tissue, the ganglia were transferred to a 5 ml dissecting
solution containing collagenase D (1.8-2.0 mg/ml; Roche,
Indianapolis, Indiana, USA) and trypsin (1.2-1.5 mg/ml;
Sigma, St Louis, Missouri, USA) and incubated for 1.5 h
at 34.5°C. DRGs were taken from the enzyme solution,
washed and transferred to 0.5 ml of the dissecting solu-
tion containing DNase (0.5 mg/ml; Sigma, St Louis,Figure 1 NMD enhanced CBS expression in rats with visceral hyperse
NMD. NMD significantly reduced distention threshold when compared wit
**P<0.01), 9 weeks (B, n=8 for each group, **P<0.01), 12 weeks (C, n=8 rats
threshold when compared with age-matched controls at the 15 weeks (D,
expression after NMD. NMD significantly upregulated expression of CBS an
7 weeks (E, n=3 rats for each group; *P< 0.05), 9 weeks (F, n=3 rats for eac
*P<0.05). NMD did not significantly alter CBS expression when compared w
Actin was used as an internal control for each group.Missouri, USA). A single cell suspension was sub-
sequently obtained by repeated trituration through
flame-polished glass pipettes. Cells were plated onto
acid-cleaned glass coverslips. Coverslips containing ad-
herent DRG cells were put in a small recording chamber
(1 ml volume) and attached to the stage of an inverted
microscope (Olympus IX71) fitted for both fluorescence
and bright-field microscopy. DiI-labeled neurons were
identified by their fluorescence under the fluorescent
microscope. For the patch-clamp recording experiments,
cells were continuously superfused (1.5 ml/min) at room
temperature with normal external solution containing
(in mM): 130 NaCl, 5 KCl, 2 KH2PO4, 2.5 CaCl2,
1 MgCl2, 10 HEPES, 10 glucose, with pH adjusted to 7.2
with NaOH, osmolarity: 295–300 mOsm). Recording
pipettes were pulled from borosilicate glass tubing using
a horizontal puller (P-97, Sutter Instruments). Unless
indicated, patch-clamp pipettes had a resistance of
4–7 MΩ when filled with the pipette solution con-
taining (in mM): 140 potassium gluconate, 10 NaCl,nsitivity. (A-D). Time course of changes in distention threshold after
h age-matched controls at the 7 weeks (A, n=8 rats for each group,
for each group, *P<0.05). NMD did not significantly alter distention
n=8 rats for each group). (E-H). Time course of changes in CBS
d increased AWR scores when compared with age-matched controls at
h group, *P<0.05), and 12 weeks (G, n=3 rats for each group;
ith age-matched controls at 15 weeks (H, n=3 rats for each group).
Figure 2 CBS inhibitor AOAA attenuated AWR scores in NMD
rats. (A) CBS inhibitor abolished visceral hyperalgesia induced by NMD
in a dose dependent manner. The maximal effect was at 10 mg/kg
body weight (i.p.) in this study. n=8 rats for each dose group; *P<0.05.
(B) CBS inhibitor mitigated visceral hyperalgesia induced by NMD
time-dependently. AOAA-induced antinociceptive effect lasted for
about 60 minutes in both 10 and 20 mg/kg body weight. n=8 rats for
each group; *P<0.05. (C) AOAA (10 mg/kg body weight) had no effect
on AWR scores of age-matched healthy control rats (n=8).
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7.25 adjusted with KOH; osmolarity: 292 mOsm. The
voltage was clamped at −60 mV by a HEKA EPC10 patch
clamp amplifier (HEKA; Germany). Capacitive transients
were corrected using capacitive cancellation circuitry on
the amplifier that yielded the whole cell capacitance and
access resistance. Up to 90% of the series resistance was
compensated electronically. Considering the peak out-
ward current amplitudes of smaller than 10 nA, the
estimated voltage errors from the uncompensated series
resistance would be smaller than 10 mV. The leak cur-
rents at −60 mV were always smaller than 20 pA
and were not corrected. The currents were filtered at
2–5 kHz and sampled at 50 or 100 μs/point. Whole
cell current and voltage were recorded with a HEKAEPC10 patch-clamp amplifier; and data were acquired
and stored on a computer for later analysis using Fit-
Master (HEKA; Germany). All experiments were per-
formed at room temperature (~22°C).
Drug application
O-(Carboxymethyl) hydroxylamine hemihydrochloride
(AOAA, an inhibitor of CBS), NaHS and pyrrolidine
dithiocarbamate (PDTC, an inhibitor of p65) were pur-
chased from Sigma-Aldrich and were freshly prepared in
0.9% normal saline. To keep consistency, AOAA were
intraperitoneally injected 30 min before behavioral mea-
surement or injected once daily for consecutive 7 days
for molecular expression experiments as described pre-
viously [8,30]. PDTC was intrathecally injected once
for behavioral test or once daily for continuous 7 days
for detection of target protein expression. NaHS at dif-
ferent doses was injected intrathecally.
Data analysis
All data are expressed as mean ± SEM. Statistical ana-
lysis were conducted using commercial software Origi-
nPro 8 (OriginLab, US) and Matlab (Mathworks, US).
Normality was checked for all data before analyses. Sig-
nificance was determined using paired sample t-Test,
paired sample sign test, two sample t test, Mann–Whitney
test, Tukey post hoc test following Kruskal-Wallis
ANOVA or two-way repeated-measures ANOVA, Mann–
Whitney test following Friedman ANOVA, as appropriate.
The level of significance was set at p < 0.05.
Results
NMD increases CBS expression in an association with
enhanced visceral hypersensitivity
Chronic visceral hyperalgesia (CVH) was determined by
measuring the distention threshold (DT) in response to
CRD at 7–15 weeks of age. The DT was significantly
lower in NMD-treated rats at 7 weeks (Figure 1A,
**p < 0.01, n=8 for each group, two sample t test), 9
weeks (Figure 1B, **p < 0.01, n=8 for each group, two
sample t test), 12 weeks (Figure 1C, *p < 0.05, n=8 for
each group, two sample t test) than those in age
matched control (CON) rats, respectively. The reduced
DTs lasted for ~6 weeks and returned to the normal level
at 15 (Figure 1D, n=8 for each group) weeks of age,
which is consistent with our previous report that NMD
significantly increased AWR scores to CRD in adult rats
compared with age-matched controls [32].
To determine the effect of NMD on CBS expression,
bilateral thoracolumbar (T13, L1, L2) DRGs were dis-
sected out at 7, 9, 12 and 15 weeks. NMD remarkably
increased CBS expression in T13-L2 DRGs at 7, 9 and
12 weeks when compared with age-matched controls.
CBS expression was returned to the normal level 15 weeks
Figure 3 CBS inhibitor AOAA reduced neuronal excitability. (A). An example of a Dil-labeled DRG neuron (Left, arrow). A phase image of the
same DRG neuron is shown on the right (arrow). Bar=50 μm. Patch clamp recordings were made from Dil-labeled neurons isolated from T13-L2
DRGs. AOAA was intraperitoneally injected at the dose of AOAA 10 mg/kg body weight once a day for consecutive 7 days. (B) Administration of
AOAA did not produce any effect on resting membrane potentials (RP). n=20 cells for each group. (C) Administration of AOAA, however,
significantly increased rheobase when compared with NS-treated NMD rats. n=20 cells for each group; **P<0.01. (D) Representative traces of APs
were induced by 300 ms depolarizing current pulses injected through the patch pipette at 2 times and 3 times rheobase in DiI labeled neurons
from NS- (left) and AOAA- (right) treated NMD rats under current-clamp conditions. (E) Bar graph showed the average number of APs evoked by
3 times rheobase current stimulation was significantly reduced while the average number of APs evoked by 2 times rheobase current stimulation
was not significantly reduced when compared with NS group. n=20 cells for each group; *P<0.05.
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etry were 1.69 (Figure 1E, n=3 for each group, *p < 0.05,
two sample t test), 2.11 (Figure 1F, n=3 for each group,
*p < 0.05, two sample t test), 3.69 (Figure 1G, n=3 for
each group, *p < 0.05, two sample t test) and 1.13
(Figure 1H, n=3 for each group, p >0.05) for 7, 9, 12 and
15 weeks, respectively. Thus, NMD treatment upregu-
lated CBS expression in colon related DRGs, suggesting a
correlation between the enhanced visceral sensitivity and
CBS expression in terms of time course in NMD rats.
CBS inhibitor AOAA attenuates AWR scores in NMD rats
To determine whether CBS activity is involved in NMD-
induced visceral hypersensitivity, CBS inhibitor, AOAA,
was administrated intraperitoneally (i.p.). Injection of
AOAA significantly reduced AWR scores in NMD rats,
in a dose-dependent fashion (Figure 2A, n = 8 for each
group; *p < 0.05 vs. NS, Tukey post hoc test following
Kruskal-Wallis ANOVA). The optimized dose for AOAA
to produce the maximal effect was 10 mg/kg body
weight in this study. We then determined the timecourse of AOAA effects. The effect of AOAA at doses of
10 and 20 mg/kg body weight lasted for ~60 min
(Figure 2B, n = 8 for each group; *p < 0.05 vs. NS, Tukey
post hoc test following two-way repeated-measures
ANOVA). Maximal inhibition was at 30 min. To fur-
ther confirm the AOAA effect on NMD rats, AOAA at
10 mg/kg was i.p. injected into age-matched healthy con-
trol rats. Application of AOAA had no significant effects
on AWR scores in healthy control rats (Figure 2C, n = 8
for healthy group). These data suggest that this agent
did not act as a non-specific analgesic and that CBS do
not normally participate in the responses to CRD in rats
under normal conditions.
CBS inhibitor AOAA reverses hyperexcitability of colon-
innervating neurons
Since AOAA attenuated the AWR scores in NMD rats,
we next investigated whether AOAA suppressed excit-
ability of DiI-labeled DRG neurons. To determine the ef-
fect of AOAA on neuronal excitability, NMD rats were
divided into two groups: AOAA group treated with
Figure 4 NaHS enhanced neuronal excitability. (A) NMD significantly decreased the rheobase comparing with CON. n=28 cells for CON, n=41
cells for NMD. **P<0.01. Similarly, NaHS application significantly decreased the rheobase comparing with PRE. n=13 cells, **P<0.01. (B) NMD failed
to change AP threshold compared with control. n=41 and 27 cells for NMD and CON, respectively. However, NaHS application markedly
hyperpolarized AP thresholds. n=13,*P<0.05. (C) Representative traces of APs were induced by 300 ms depolarizing current pulses at 2 times and
3 times rheobase in DiI labeled neurons from control and NMD rats (far two left traces) and DiI labeled neurons from healthy control rats before
and after NaHS application (far two right traces) under current-clamp conditions. (D) Bar graph showing that NMD treatment significantly
increased average number of APs elicited by a 2 or 3 times rheobase current injection of DiI neurons compared with controls (left). n=25 and 21
cells for CON in 2 times and 3 times rheobase stimuli, respectively, n=40 and 36 cells for NMD in 2 times and 3 times rheobase stimuli,
respectively. *P<0.05. Similarly, application of NaHS remarkably increased the number of APs evoked by 2 and 3 times current stimulation (right).
n=13 cells for each group in 2 times rheobase stimuli, n=9 cells for each group in 3 times rheobase stimuli. *P<0.05, **P<0.01.
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same volume of normal saline (NS, i.p.). Colon specific
DRG neurons (Figure 3A) were harvested 4.5 hours after
termination of the last injection. AOAA treatment
did not significantly change the resting membrane
potentials (Figure 3B). The resting membrane potentials
were −51.90±1.73 (n=20 cells) and −51.45±1.33 (n=20
cells) for NS and AOAA, respectively. However, AOAA
treatment dramatically enhanced rheobase when com-
pared with the NS-treated group (Figure 3C, NS: 0.02 ±
0.003 nA; AOAA: 0.07 ±0.01 nA, n =20 cells for each
group, **p < 0.01. Mann–Whitney test). In addition,
AOAA injection markedly decreased the number of ac-
tion potentials (APs) evoked by 3X rheobase current
stimulation (Figure 3D and E), but not by 2X rheobase
current stimulation. The average numbers of APs evoked
by 2X rheobase stimulation were 2.75 ± 0.26 and 2.35 ±
0.22 for NS and AOAA (n=20 cells for each group), re-
spectively (Figure 3E, left, p>0.05). The average numbers
of APs evoked by 3X rheobase stimulation were 3.70 ±
0.33 and 2.60 ± 0.28 for NS and AOAA (n=20 cells for
each group), respectively (Figure 3E, * p < 0.05, Mann–
Whitney Test).Addition of NaHS enhances neuronal excitability
Since the production of CBS enzyme is H2S, we then
determined the role for H2S on neuronal excitability.
NaHS, a donor for H2S, was applied in the study. Appli-
cation of NaHS is to mimic CBS production of H2S. The
reason to apply NaHS is because its use enables us to
define H2S concentrations in the solution more accur-
ately and reproducibly than directly bubbling H2S gas.
In the neutral pH solution, one-third of NaHS exists as
H2S and the remaining two-thirds are present as HS
−.
To better compare the effect of H2S and NMD-induced
effect on neuronal excitability, we firstly examined the
rheobase, AP threshold and numbers of AP evoked by
2X and 3X rheobase current stimulation in NMD rats.
In an agreement with our previous report [33], NMD
treatment markedly reduced the rheobase (Figure 4A,
CON: 0.24 ± 0.02 nA, n =28; NMD: 0.17 ± 0.02 nA,
n =41; **p < 0.01, Mann–Whitney test), and increased
the number of APs in response to 2 times rheobase
current stimulation (Figure 4C and D, CON: 1.05 ± 0.34,
n =25 neurons; NMD: 2.64 ± 0.49, n = 40 neurons;
*p < 0.05, Mann–Whitney test) and 3 times rheobase
current stimulation (Figure 4C and D, CON: 1.96 ± 0.11,
Figure 5 NaHS reduced distention threshold. Intrathecal (i.t.)
injection of NaHS significantly attenuated the distention threshold in
a dose-dependent fashion. NaHS with different concentrations was
injected in a volume of 30 μl. The same volume of normal saline
(NS) was injected (i.t.) as control. (A) NaHS at 0.01 nM did not
produce any effect on distention threshold compared with NS
group. (B) NaHS at 0.1 nM significantly reduced distention threshold
compared with NS group. (C) NaHS at 1 nM remarkably reduced
distention threshold compared with NS group. n=6 rats for each
group. *p<0.05.
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*p < 0.05, Mann–Whitney test). However, NMD did
not significantly alter the AP threshold (Figure 4B,
CON: -16.78 ± 2.02 mV, n = 27 neurons; NMD: -18.37 ±
1.13 mV, n = 41 neurons). These data further support pre-
vious conclusion that excitability of colon specific DRG
neurons was enhanced after NMD treatment. We next
defined the role for NaHS on TL DRG neurons from
healthy control rats. Incubation of these neurons with
freshly prepared NaHS (250 μM) for 3 min significantly
decreased the rheobase (Figure 4A, PRE: 0.18 ± 0.03 nA;
NaHS: 0.08 ± 0.01 nA; n = 13 cells; **p < 0.01, paired sam-
ple sign test) and hyperpolarized the threshold of action
potentials (Figure 4B, PRE: -22.11 ± 3.63 mV; NaHS:
-33.53 ± 2.34 mV; n = 13 cells; *p < 0.05, paired samplet-Test). Additionally, application of NaHS also increased
the numbers of APs evoked by 2 times and 3 times rheo-
base current stimulation in TL DRG neurons from healthy
control rats. The average numbers of APs after NaHS ap-
plication were significantly higher than those before NaHS
application (Figure 4D, Pre: 1.54 ± 0.22; NaHS: 2.85 ±
0.44; n = 13 cells, 2X rheobase; **p < 0.01, paired sample
sign test. Pre: 1.11 ± 0.11; NaHS: 3.33 ± 0.82; n = 9 cells,
3X rheobase; *p < 0.05, paired sample sign test). These
data suggest that H2S donor NaHS mimics the effect of
NMD.
Administration of NaHS reduces distention threshold
If H2S generated endogenously contributes to the initi-
ation and maintenance of visceral hyperalgesia in NMD
animals, then application of exogenous H2S to healthy
rats should mimic the effects of NMD. Therefore, we ap-
plied NaHS to healthy rats and assessed behavioral
responses. Intrathecal administration of NaHS, which is
used to mimic the CBS production of H2S, led to a sig-
nificant decrease in distention threshold in normal rats,
in a dose-dependent manner (Figure 5). Application of
0.01 nM NaHS in 30 μL did not produce any effect on
distention threshold (Figure 5A). Application of 0.1 nM
(Figure 5B) and 1 nM (Figure 5C) NaHS in 30 μL signifi-
cantly reduced distention threshold (n=6 for each group,
* p < 0.05, Tukey post hoc test following two-way
repeated measures ANOVA), and the effect of drug ap-
plication lasted for at least 30 min. The maximal inhibi-
tory rate was 21% and 25% for 0.1 nM and 1 nM NaHS,
respectively. These data demonstrate that H2S produces
acute hyperalgesic effect in healthy rats, which partially
mimics the effect induced by NMD.
NMD promotes nuclear translocation of NF-κB
Because NF-κB plays an important role in inflammatory
and neuropathic pain [15,16], we next determined
whether NF-kB plays a role in NMD-induced visceral
hyperalgesia. Since p65 is a major component in the NF-
kB complex activation and predominantly expressed in
small- and median-sized DRG neurons [34], we selected
to examine p65 translocation to the nucleus by Western
blotting. We first examined the distribution of p65 in
cytoplasm and nuclear in DRGs from rats 7 weeks after
NMD and from age-matched control rats. In NMD rats,
the p65 in cytoplasm is greatly decreased compared with
the controls (Figure 6A, * p < 0.05, two sample t test).
The relative densitometry of p65 expression in cyto-
plasm was 0.97±0.13 (n=5) and 0.53±0.06 (n=4) for
CON and NMD, respectively. NMD reduced cytosolic
p65 expression by 45.32%. However, the relative densi-
tometry of nuclear fraction of p65 was more in NMD
rats than in controls (Figure 6B, * p <0.05, two sample
t test). The relative densitometry of p65 expression in
Figure 6 Effect of NMD on p65 translocation. Colon-innervating DRGs (T13-L2) were harvested from control (CON) and NMD rats. After cell
fraction, 20 μg of nuclear and 40 μg of cytosolic fractions were used for p65 western blotting. (A) Original Western blots demonstrating
expression of p65 subunit of NF-κB protein (upper) in cytosolic fractions from control (left) and NMD (right) rats. β-Actin (lower panel) was used
as a loading control. Quantification of the bands by densitometry showing that the content of p65 in the cytoplasm was significantly lower in
NMD group than in CON group. n=5 rats for CON, n=4 rats for NMD; *P<0.05. (B) Original Western blots demonstrating expression of p65 subunit
(upper) in nuclear fractions from control (left) and NMD (right) rats. Histone 3 (H3, lower panel) was used as a loading control. Quantification of
the bands by densitometry showing that the content of p65 in the nuclear was significantly higher in NMD group than in CON group. n=3
samples for each group, 4 rats in each sample; *P<0.05. Thus, NMD promotes p65 translocation from cytoplasm to nucleus in colon-innervating
DRGs.
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NMD (n=3 samples for each group,4 rats in each
sample), respectively. NMD increased nuclear p65 ex-
pression by 247.98%. Thus, translocation of p65 from
the cytosol into the nucleus was evident after NMD.
p65 Inhibitor PDTC reverses upregulation of CBS
expression and mitigates visceral hyperalgesia
Since activation of NF-κB was observed, the possibility
of kappaB-dependent gene expression in response to ex-
posure to NMD was investigated. To determine the rela-
tionship between NF-κB and CBS upregulation, PDTC,
an inhibitor of p65, was used in this study. PDTC (1 μg
in 30 μl) was intrathecally injected daily for consecutive
7 days in NMD rats. NS injection was used as control.
Proteins were isolated from T13-L2 DRGs of those rats.
After PDTC treatment, the level of CBS expression was
decreased markedly when compared with NS treatment
group (Figure 7A, PDTC/NS =0.62, n = 3 for each
group; *p < 0.05, two sample t-test). Thus, inhibition of
NF-κB abrogates CBS upregulation by NMD.
We next examined the effect of PDTC treatment on vis-
ceromotor responses to CRD. Three different doses were
used in this experiment. PDTC attenuated AWR scores in
NMD rats in a dose- and time- dependent manner
(Figure 7B and C). Two doses (1μg and 10 μg in 30 μl)
attenuated AWR scores at different distention pressures
when compared with NS group (Figure 7B, n=8 for each
groups, * p<0.05, Tukey post hoc test following Kruskal-
Wallis ANOVA). The maximal effect was at 10 μg/rat.The time course of PDTC effect was also examined. As
shown in Figure 7C, the distention threshold was mea-
sured after NS or PDTC treatment. Three doses of PDTC
significantly reduced distention threshold 30 min after
PDTC injection while only two doses (1 and 10 μg) re-
markably reduced the distention threshold 60 min after
PDTC injection when compared with NS injection
(Figure 7C, n=8 for each groups, * p<0.05, Tukey post
hoc test following two-way repeated measures ANOVA).
PDTC effect disappeared 90 min after treatment.
Discussion
Our present study showed that NMD produced visceral
hypersensitivity in adult Sprague–Dawley rats, which
was manifested as a reduction in distention threshold in
response to CRD in adult rats compared with age-
matched controls. The reduced distention threshold
lasted for ~6 weeks (Figure 1). As an extension from a
previous study, we showed that NMD reduced the dis-
tention threshold to elicit visceromoter responses to
CRD [35]. Our result is consistent with previous studies
and supported the idea that early life stress could trigger
visceral hyperalgesia and colonic dysfunction [2,36-38].
To elucidate the mechanism by which NMD enhanced
visceral sensitivity, we analyzed expression of the endogen-
ous hydrogen sulfide producing enzyme CBS in colon-
innervating DRGs. We found that NMD greatly upregu-
lated CBS enzyme expression (Figure 1). This upregulation
was well paralleled with reduced distention threshold in
terms of time course, indicating a close correlation
Figure 7 PDTC reduced CBS expression and attenuated visceral
hypersensitivity. (A) Original Western blots demonstrating
expression of CBS protein (upper) from NS (left) and PDTC (right)
treated rats. β-Actin (lower panel) was used as a loading control.
Quantification of the bands by densitometry showing that the
intrathecal injection of PDTC at 1 μg once a day for consecutive 7
days remarkably inhibited CBS expression. n=3 rats for each group.
*P<0.05. (B) Intrathecal injection of different doses of PDTC reduced
the AWR scores compared with NS treatment, in a dose-dependent
manner. n=8 rats for each group. *P<0.05. (C) Time course of PDTC
effect. Administration of PDTC greatly enhanced the distension
threshold on NMD rats for ~60 min compared with NS-treated rats.
n=8 rats for each group. *P<0.05.
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this model. To further confirm the involvement of CBS in
NMD-induced visceral pain, AOAA, an inhibitor of CBS,
was administrated. AOAA remarkably attenuated the
AWR scores in NMD rats in a time- and dose-dependent
manner. This is consistent with our previous report that
hydroxylamine (HA), another CBS inhibitor, significantly
attenuated the AWR scores in rats with neonatal colonic
inflammation [8]. The reason for using AOAA but not HA
in the present study is because HA has a COX-1 inhibitory
action [39]. Of note is that AOAA did not produce any ef-
fect in age-matched healthy control rats, suggesting that
AOAA had a specific effect under visceral pain conditions.
AOAA treatment remarkably reduced excitability ofcolon-innervating DRG neurons (Figure 3), as was evi-
denced by our findings that AOAA significantly increased
the rheobase and decreased number of APs evoked by 3
times current stimulation. In this study, AOAA treat-
ment did not produced any effect on resting membrane
potentials of colon specific DRG neurons. Thus, a in-
crease in the rheobase and decrease in the number of ac-
tion potentials evoked by current stimulation is not due
to alteration of resting membrane potentials. This raised
a possibility that functions of voltage-gated Na+ and/or
K+ channels may be modified following AOAA treatment
because these channels are major determinant factors for
rheobase and action potential firing. Although the
detailed mechanisms have yet to be elucidated in future,
our findings indicate that the reduction in visceromotor
responses to CRD by AOAA application may be attribu-
ted to the reduced excitability of colon-innervating DRG
neurons.
To further confirm the role for CBS-H2S signaling, we
examined the effect of H2S on neuronal excitability of
colon-innervating DRG neurons. NaHS, a donor of H2S,
was added to mimic CBS production of H2S [40]. NaHS
greatly enhanced excitability of colon-innervating DRG
neurons acutely isolated from healthy control rats
(Figure 4). This was evidenced by our findings that NaHS
significantly decreased the rheobase, hyperpolarized the
AP threshold and increased the numbers of APs evoked
by 2 times and 3 times current stimulation. Interest-
ingly, in this study we also found that NMD markedly
reduced the rheobase and increased the number of action
potentials evoked by 2 times and 3 times rheobase
current stimulation of colon-innervating DRG neurons,
a phenomena which is very similar to NaHS effects.
Furthermore, intrathecal injection of NaHS significantly
decreased the distention threshold in response to CRD
in healthy control rats (Figure 5). Together, these
results suggest that CBS-H2S signaling was involved in
the development of visceral pain induced by NMD.
It was noteworthy that CBS enzyme upregulation was
correlated with the increase in the amount of NF-κB (p65)
in the cell nucleus. NF-κB, a pivotal player in inflammatory
responses and neuropathy, is constitutively expressed in
the primary sensory neurons and glial cells in dorsal root
ganglion [41]. It is known that NF-κB participates in pain
processes, an effect attributed to the effect of NF-κB on
gene transcription. NF-κB is bound to the inhibitory pro-
tein IκB, which retains NF-κB within the cytosol thus pre-
venting its transcriptional activity. In this study, we
demonstrated that the amount of p65 protein in the cell
cytoplasma was reduced by ~45% while the amount of p65
protein in the cell nucleus was enhanced by ~248% after
NMD (Figure 6). This suggests that NMD promoted trans-
location of p65 from cytoplasma to nucleus. This NF-κB
activation is critical in the induction of CBS expression
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CBS expression (Figure 7A). More importantly, NF-κB
translocation is involved in the induction of visceral hyper-
sensitivity in NMD rats since application of PDTC mark-
edly attenuated AWR scores in a dose- and time-
dependent fashion (Figure 7B and C). Collectively, our
findings suggest that PDTC may exert antinociceptive ef-
fect by inhibiting NF-kB-mediated CBS expression. It is of
note that NMD-evoked dramatic increase in p65 protein
expression in nucleus may not be explained simply by the
enhanced translocation. An upregulation of total p65 pro-
tein expression cannot be ignored since the 45% reduction
in cytoplasma may not account for the 248% increase in
nucleus. Regulatory mechanism at transcriptional level
should be considered. Future studies are needed to deter-
mine whether NF-KB mediated-CBS upregulation is a dir-
ect transcriptional regulation or an indirection interaction.
Nevertheless, enhanced translocation might play a critical
role in mediating CBS expression. Although no common
second messenger has been identified, most NF-κB activat-
ing signals can be inhibited by antioxidants because critical
steps such as protein phosphorylation and binding of tran-
scription factors to consensus sites on DNA are regulated
by the intracellular redox status. Future researches are
needed to investigate this mechanism since H2S produc-
tion was increased in DRG cells due to its ability to activate
NF-κB by increasing the intracellular redox state.
Taken together, p65 is a signal transducer that modu-
lates CBS-H2S signaling pathway, which in turn affects
colon-innervating sensory neuron excitability and
thereby contributing to the chronic visceral pain seen in
NMD rats. Thus, NF-κB inhibitors may be promising
candidates for treating visceral pain in patients with
functional gastrointestinal disorders such as IBS.
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